iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.
iVEAcare has raised $27.5M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
iVEAcare's investors include Hatteras Venture Partners, Vensana Capital, Treo Ventures.
iVEAcare is headquartered in Minneapolis, United States.
iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.
iVEAcare is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iVEAcare — Funding & Investors." VCBacked, April 22, 2024, https://www.vcbacked.co/company/iveacare. Accessed October 5, 2026.
VCBacked. (2024). iVEAcare — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/iveacare
{{cite web |title=iVEAcare — Funding & Investors |url=https://www.vcbacked.co/company/iveacare |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated